Amorphical brings Scientific Breakthrough - Treating and Curing Chronic Inflammatory and Oncological Diseases

27 Nov 2023
www.prnewswire.com
NES-ZIONA, Israel, Nov. 27, 2023 /PRNewswire/ -- An exclusive initiative by the Israeli biotechnology company Amorphical brings a breakthrough approach to treating a variety of chronic inflammatory and oncological diseases.
Scientific Development and Breakthrough
Amorphical has developed a pioneering technology to produce amorphous nano-minerals.
The unique structure of these amorphous nano-minerals enables the efficient and rapid absorption of essential minerals in the body.
Amorphous nano-minerals also possess a unique ability to stimulate healing mechanisms within the target damaged tissues.
Amorphous Calcium Carbonate – Amorphical's Revolutionary Leading Product
Calcium is a vital mineral for various physiological activities: bone formation, nerve conductivity, muscle function, boosting the immune system, and many other activities.
Carbonate is a crucial molecule for maintaining the body's pH balance by neutralizing excess acidity.
Treating the Cause for Disease, Not Just the Symptom
Modern lifestyle, characterized by stress, unbalanced diet, and an increase in life expectancy, results in a reduced production of bicarbonate, essential for the proper function of the body. Consequently, the elevated tissue acidity impairs the ability to regulate inflammatory processes, ultimately leading to the development of chronic inflammatory as well as oncological diseases.
Due to its unique structure and dissolving properties, unlike the crystalline mineral, the amorphous calcium carbonate can directly target inflamed or cancerous tissues.
When amorphous carbonate calcium reaches the inflamed tissue, a neutralizing reaction occurs within the acidic environment. The resulting neutral environment does not support the inflammatory processes, leading to the desired healing.
Neutralizing the acidic environment is also crucial in treating oncological diseases. Most oncological diseases are characterized by anaerobic respiration of cancer cells, creating an acidic environment within the tumor. This acidic environment supports the rapid division of cancer cells and the development of metastases, while preventing the immune system from attacking and eliminating the cancer cells.
Neutralizing the acidic environment in the cancerous tissue by amorphous calcium carbonate inhibits the enhanced metabolic activity of the cancer cells, required for their rapid division.
In parallel to the reduction in cancer cell proliferation, the neutralization of the acidic environment within the tumor allows the immune cells to resume their activity, and attack and destroy the cancer cells.
To date, this is the sole technology capable of treating and curing a wide range of oncological diseases by transforming the cancerous environment into a healthy environment.
Comparison to Current Medications
Current medications for chronic inflammatory diseases primarily aim to alleviate symptoms rather than target the disease accelerator, which is the acidic environment within the inflamed tissue. In contrast, amorphous calcium carbonate neutralizes the acidic environment specifically in the inflamed tissue, and thus enables the healing of the inflammation.
Conditions Suitable for Treatment by Amorphous Calcium Carbonate
The innovative treatment with amorphous calcium carbonate promotes prompt and effective recovery across a variety of diseases:
2.  A wide range of oncological diseases including breast, prostate, colon, liver cancers, and  more.
3.  The treatment has proven to be highly effective in managing COVID-19.
4.  The treatment significantly slows down aging processes and substantially improves the quality of life.
Selected Scientific Publications on the Medical Activity of Amorphical's Nano-Amorphous Calcium Carbonate:
Amorphous Calcium Carbonate Shows Anti-Cancer Properties That are Attributed to Its Buffering Capacity. Cancers (Basel). 2023 Jul 26;15(15):3785
Treatment for COVID-19:
Sublingual and Inhaled Amorphous Calcium Carbonate for Hospitalized Patients with SARS-CoV-2: A Phase 1/2 Clinical Study. J Clin Trials. 2023 Vol.13 Iss. 4 No: 1000551
Effect on Mouse Embryos:
The effect of amorphous calcium carbonate as a culture media supplement on embryonic development of murine sibling embryos. J Assist Reprod Genet. 2023 Oct;40(10):2409-2418
Additional articles describing the treatment with Amorphical's amorphous nano-minerals are presented on the company's website.
For more information, please contact: Noga Nadel Erental - [email protected]
Logo - https://mma.prnewswire.com/media/2285885/Amorphical_Logo.jpg
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.